Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Dec 10 2024

Full Issue

Supreme Court Won't Hear PhRMA Appeal Of Arkansas' Contract Pharmacy Law

The drug industry's application for a hearing was declined by the Supreme Court Monday. Arkansas' law allows hospitals to use contract third-party pharmacies while participating in the federal 340B discount program. Other states have similar laws.

The U.S. Supreme Court on Monday declined to hear an appeal by the nation's leading drug industry group challenging an Arkansas law requiring pharmaceutical companies to offer discounts on drugs dispensed by third-party pharmacies that contract with hospitals and clinics serving low-income populations. (Pierson, 12/9)

And in administration news —

A commonly prescribed antidepressant has been recalled across the U.S. due to fears of contamination with a potentially cancer-causing chemical. 233,003 bottles of the drug, named Duloxetine, were voluntarily recalled by their distributor, Rising Pharmaceuticals, Inc.—based in East Brunswick, New Jersey—on November 19. ... The recalled drugs have now been issued a "Class II" risk level by the U.S. Food and Drug Administration (FDA). (Thomson, 12/9)

A red food dye prevalent in candies, drinks and other products could soon be banned in the United States if federal regulators side with a petition that is under review. The Food and Drug Administration has signaled that it may finally crack down on the use of the additive known as red dye No. 3, an artificial dye that gives a cherry-red coloring to thousands of American products. While the FDA has claimed that red 3 ... can be safe to consume, advocates have long called for its ban amid concerns that the food dye is linked to cancer and behavioral problems in children. (Lagatta, 12/9)

The Environmental Protection Agency on Monday banned two solvents found in everyday products that can cause cancer and other serious diseases. It was a move long sought by environmental and health advocates, even as they braced for what could be a wave of deregulation by the incoming Trump administration. For decades, communities close to factories, airports, dry cleaners and other sites have lived with the consequences of exposure to trichloroethylene, or TCE, a toxic chemical used in cleaners, spot removers, lubricants and glue. (Tabuchi, 12/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ